Realcan Pharmaceutical Group Co., Ltd. (SHE:002589)
3.260
+0.040 (1.24%)
Sep 7, 2026, 3:04 PM CST
SHE:002589 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 5,747 | 3,745 | 4,984 | 5,061 | 5,340 | 4,579 |
Trading Asset Securities | 5 | - | - | - | - | - |
Cash & Short-Term Investments | 5,752 | 3,745 | 4,984 | 5,061 | 5,340 | 4,579 |
Cash Growth | -3.80% | -24.87% | -1.52% | -5.23% | 16.63% | -20.97% |
Accounts Receivable | 3,843 | 4,176 | 4,375 | 4,222 | 4,603 | 11,276 |
Other Receivables | 674.32 | 717.08 | 893.29 | 990.01 | 1,670 | 1,897 |
Receivables | 4,518 | 4,893 | 5,269 | 5,212 | 6,274 | 13,172 |
Inventory | 631.43 | 715.3 | 734.74 | 1,119 | 954.51 | 2,068 |
Prepaid Expenses | 0.17 | - | - | 0.11 | - | 7.27 |
Other Current Assets | 121.16 | 100.42 | 96.79 | 147.07 | 250.97 | 845.88 |
Total Current Assets | 11,023 | 9,453 | 11,084 | 11,539 | 12,820 | 20,672 |
Property, Plant & Equipment | 1,997 | 2,018 | 2,239 | 2,277 | 2,297 | 2,527 |
Long-Term Investments | 921.33 | 821.33 | 746.72 | 852.03 | 594.07 | 805.82 |
Goodwill | 146.67 | 146.67 | 146.67 | 146.67 | 146.69 | 620.27 |
Other Intangible Assets | 488.25 | 506.7 | 440.89 | 552.39 | 624.21 | 478.35 |
Long-Term Accounts Receivable | - | - | - | - | - | 0.07 |
Long-Term Deferred Tax Assets | 312.03 | 321.59 | 286.15 | 284.44 | 106.68 | 122.86 |
Long-Term Deferred Charges | 44.99 | 49.69 | 61.26 | 60.87 | 89.93 | 134.58 |
Other Long-Term Assets | 1,016 | 1,053 | 1,033 | 996.39 | 1,654 | 1,035 |
Total Assets | 15,949 | 14,370 | 16,038 | 16,709 | 18,332 | 26,397 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 4,850 | 3,760 | 3,383 | 3,723 | 7,715 | 9,791 |
Accrued Expenses | 27.48 | 38.95 | 43.03 | 66.98 | 57.68 | 227.5 |
Short-Term Debt | 4,789 | 4,201 | 6,097 | 6,556 | 3,926 | 4,440 |
Current Portion of Long-Term Debt | 172.35 | 167.83 | 155.38 | 5.6 | 6.51 | 6.3 |
Current Portion of Leases | - | 0.86 | 0.76 | 0.52 | 1.82 | 10.09 |
Current Income Taxes Payable | 0.83 | 1.52 | 3.64 | 1.68 | 5 | 91.82 |
Current Unearned Revenue | 23.16 | 9.44 | 25.13 | 29.12 | 32.43 | 174.72 |
Other Current Liabilities | 371.4 | 482.59 | 237.28 | 378.53 | 724.46 | 1,766 |
Total Current Liabilities | 10,234 | 8,662 | 9,945 | 10,761 | 12,468 | 16,508 |
Long-Term Debt | 215.28 | 234.71 | 327.08 | 261.27 | 67.2 | 48.5 |
Long-Term Leases | 1.47 | 0.93 | 4.12 | 0.84 | 2.73 | 39.19 |
Long-Term Unearned Revenue | 4.39 | 4.57 | 4.74 | 1.62 | 1.93 | 17.5 |
Long-Term Deferred Tax Liabilities | 42.76 | 44.96 | 48.5 | 47.48 | 40.58 | 83.56 |
Other Long-Term Liabilities | - | - | - | - | - | 7.28 |
Total Liabilities | 10,498 | 8,947 | 10,329 | 11,072 | 12,581 | 16,704 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 1,505 | 1,505 | 1,505 | 1,505 | 1,505 | 1,505 |
Additional Paid-In Capital | 3,477 | 3,477 | 3,634 | 3,720 | 3,701 | 4,015 |
Retained Earnings | 428.56 | 419.59 | 409.44 | 453.83 | 432.66 | 2,278 |
Treasury Stock | -101.48 | -101.48 | - | -230.65 | -230.65 | -230.65 |
Total Common Equity | 5,309 | 5,300 | 5,548 | 5,448 | 5,407 | 7,567 |
Minority Interest | 142.25 | 123.11 | 160.2 | 189.18 | 344 | 2,126 |
Shareholders' Equity | 5,451 | 5,423 | 5,709 | 5,637 | 5,751 | 9,693 |
Total Liabilities & Equity | 15,949 | 14,370 | 16,038 | 16,709 | 18,332 | 26,397 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 5,178 | 4,605 | 6,584 | 6,824 | 4,004 | 4,544 |
Net Cash (Debt) | 573.9 | -860.3 | -1,600 | -1,764 | 1,336 | 34.82 |
Net Cash Growth | - | - | - | - | 3737.34% | - |
Net Cash Per Share | 0.36 | -0.54 | -1.30 | -1.17 | 0.90 | 0.02 |
Filing Date Shares Outstanding | 1,470 | 1,470 | 1,505 | 1,496 | 1,496 | 1,496 |
Total Common Shares Outstanding | 1,470 | 1,470 | 1,505 | 1,496 | 1,496 | 1,496 |
Working Capital | 788.12 | 791.18 | 1,140 | 777.98 | 351.12 | 4,164 |
Book Value Per Share | 3.61 | 3.61 | 3.69 | 3.64 | 3.61 | 5.06 |
Tangible Book Value | 4,674 | 4,646 | 4,961 | 4,749 | 4,636 | 6,468 |
Tangible Book Value Per Share | 3.18 | 3.16 | 3.30 | 3.17 | 3.10 | 4.32 |
Buildings | 2,106 | 1,821 | 1,974 | 1,819 | 1,865 | 1,468 |
Machinery | 624.81 | 602.5 | 687.24 | 695.38 | 778.65 | 1,436 |
Construction In Progress | 18.82 | 306.18 | 307.34 | 429.34 | 315.37 | 549.58 |